baber/WOPTO huggingface dataset:
Patent JP-4241937-B2 (JP)
IPC: F15D1/12
Filed: 1998-03-16
Granted: 2009-03-18
Abstract: The invention relates to a steam turbine (1) which has a flow duct (2) with a wall (3). Blading (5) is arranged in blading rings (55) in the flow duct (2). The wall (3) of the flow duct (2) has a grooved structure (6) which purposefully influences the flow of an active fluid (13) through the flow duct (2). In particular, a spacing surface (31) with a grooved structure (6) is located between each two blades or vanes (5) of a blading ring (55). The invention also relates to a blade or vane for a steam turbine.
Patent JP-3893156-B2 (JP)
IPC: F16B7/06
Filed: 1998-03-25
Granted: 2007-03-14
Abstract: A rod anchor is threadedly connected to a tension rod. The rod anchor includes an anchor head having a threaded first bore hole formed therein, and a sealing nut attached to the anchor head in sealing relationship therewith. The sealing member forms a second bore hole axially aligned with the first bore hole, whereby a threaded end of the tension rod extends through the second bore hole and into threaded engagement with the first bore hole. The sealing nut includes sealing material forming a seal between the sealing nut and the tension rod.
Patent JP-4294737-B2 (JP)
IPC: B65B9/02
Filed: 1998-03-19
Granted: 2009-07-15
Abstract: A method and apparatus for producing filled gelatin capsules created from strips (4) of gelatin ribbon. The strips are led to an encapsulation station (6) where they are enclosed around the fill that is delivered thereto. Means are provided for controlling the lateral alignment of the strip in its path to the encapsulation station (6) preferably, such means comprises a pivotal guide bar assembly (52).
Patent PL-70352-B2 (PL)
IPC: C07D223/22
Filed: 1969-11-26
Abstract: 1295678 Dibenzo-pyrrolo-azepines CIBA GEIGY AG 26 Nov 1969 [19 Dec 1968] 57848/69 Heading C2C Novel compounds of Formula I (in which R 1 is H, CH 3 , C 2 H 5 or n-C 3 H 7 , and R 2 is H, straight chain C 1-4 alkyl, isopropyl or allyl) and their pharmaceutically acceptable acid addition salts are prepared (i) by reacting a compound of Formula II (in which R 1 <SP>1</SP> is CH 3 , C 2 H 5 or n-C 3 H 7 or a group which can be replaced by a hydrogen atom by hydrolysis) with a compound of formula H 2 NR 2 and hydrolysing an intermediate compound thus obtained when R 1 <SP>1</SP> is other than CH 3 , C 2 H 5 or n-C 3 H 7 , (ii) when R 1 is not H, by reacting a compound of Formula III with a reactive ester of methanol, ethanol or n-propanol, (iii) when R 1 is not H, by reducing a compound of Formula IV (in which R 3 is a formyl, acetyl or propionyl group) with diborane in an ethereal solution, or (iv) when R 1 is H, by hydrolysing a compound of Formula V (in which Ac is CN or the acyl radical of an organic. acid), and, if desired, converting a resulting compound I into a pharmaceutically acceptable acid addition salt thereof, or converting an acid addition salt of a compound I into the free base or into another, pharmaceutically acceptable, acid addition salt. Compounds of Formula V (in which Ac is ethoxycarbonyl) are prepared by reacting a compound of Formula I (in which R 2 is C 1-5 alkyl, allyl or benzyl) with ethyl chloroformate. 2 - Ethyl - 8 - formyl - 1,2,3,8 - tetrahydrodibenzo[b,f]pyrrolo[3,4.d]azepine is prepared by reacting 2 - ethyl - 1,2,3,8 - tetrahydrodibenzo[b,f]pyrrolo[3,4-d)azepine with formic acid. Pharmaceutical compositions having central depressant and antihistame activity, for oral, rectal or parenteral administration; comprise a compound of Formula I, or a pharmaceutically acceptable acid addition salt thereof, together with a pharmaceutical diluent or carrier.
[GB1295678A]
Patent ES-2253084-B2 (ES)
Title: Procedimiento de fabricacion por extrusion en termoplasticos de correas de encofrado con injertos para forjados planos y encofrado mecano asi obtenido.
Inventor: JIMENEZ SANCHEZ JAIME ENRIQUE
IPC: E04G11/48
Filed: 2004-11-15
Granted: 2007-02-01
Abstract: Consiste en un método de fabricación de los perfiles de los sistemas mecano de encofrado de forjados planos de la edificación, mediante técnicas de extrusión de termoplásticos con boquillas rígidas metálicos y calibradores, incluyendo en la boquilla todas las partes singulares de dichos perfiles correa y portacorrea, como aleta superior tope para los tableros, etc., taladrado en caliente para incrustar luego injertos como los tetones para puntales, topes de desplazamiento entre elementos y sistema de empalme longitudinal entre los mismos elementos, abaratando el coste del encofrado al disminuir tanto la mano de obra de fabricación como las materias primas que lo constituyen, y dando la posibilidad de reciclar los perfiles una vez se rompan o deterioren después de muchos usos. Para ello el perfil tendrá forma de cerrada de tubo de pared delgada con su sección calculada para obtener igual resistencia que con los perfiles metálicos actuales del mismo uso.
Patent ES-2291106-B2 (ES)
Title: Catalizador de aromatizacion y metodos para la preparacion y el uso del mismo.
Inventor: WU AN-HSIANG
IPC: C10G35/095
Filed: 2004-05-12
Granted: 2009-11-11
Abstract: Catalizador de aromatización y métodos para la
preparación y el uso del mismo, que comprende impregnar un soporte
de zeolita de poro grande con un precursor de platino y al menos un
precursor de haluro de amonio orgánico. En una realización, el
precursor de haluro de amonio se representa por la fórmula
N(R)_{4}X, en la que X es un haluro y R  es una
molécula de cadena de carbono sustituida o sin sustituir que tiene
1-20 átomos de carbono, en la que cada R  puede ser
igual o diferente. En una realización, el precursor de haluro de
amonio comprende al menos un haluro    ácido y al menos un hidróxido
de amonio representado por la fórmula N(R')_{4}OH, en la
que R' es hidrógeno o una molécula de cadena de carbono sustituida o
sin sustituir que tiene 1-20 átomos de carbono, en
la que cada R' puede  ser igual o diferente. un procedimiento para
la aromatización de un hidrocarburo que utiliza dicha composición de
 catalizador.
Patent AU-2001257627-B2 (AU)
Title: Methods for preparing cla isomers
Inventor: SAEBO PER CHRISTIAN
IPC: C07C69/003
Filed: 2001-04-24
Granted: 2006-06-22
Abstract: Novel compositions containing conjugated linoleic acid isomers can be used for controls in gas chromatography and for animal feeding studies. Purified isomers of conjugated linoleic acid can be treated to produce a preparation containing two isomers of CLA. The preparation can be used as is or further processed to separate the two isomers. The isomers can be used in their free fatty acid form or converted to alkylesters or triglycerides. Furthermore, the isomers are useful as supplements for food products or feed.
Patent AU-2001277253-B2 (AU)
Title: Process and system for producing multicomponent spunbonded nonwoven fabrics
Inventor: ALEXANDER ROBERT C
IPC: D04H3/14
Filed: 2001-08-02
Granted: 2005-07-28
Abstract: A system and process is provided for producing spunbond nonwoven fabric. Two or more polymeric components are separately melted and are separately directed through a distribution plate configured so that the separate molten polymer components combine at a multiplicity of spinnerette orifices to form filaments containing the two or more polymer components. Multicomponent filaments are extruded from the spinnerette orifices into a quench chamber where quench air is directed from a first independently controllable blower and into contact with the filaments to cool and solidify the filaments. The filaments and the quench air are directed into and through a filament attenuator and the filaments are pneumatically attenuated and stretched. The filaments are directed from the attenuator into and through a filament depositing unit and are deposited randomly upon a moving continuous air-permeable belt to form a nonwoven web of substantially continuous filaments. Suction air from a second independently controllable blower beneath the air-permeable belt so is drawn through the depositing unit and through the air-permeable belt and web is then directed through a bonder for bonding the filaments to convert the web into a coherent nonwoven fabric.
Patent AU-2001286454-B2 (AU)
Title: Substituted pyrazoles
Inventor: MEDUNA STEVEN P
IPC: C07D413/14
Filed: 2001-08-10
Granted: 2006-09-14
Abstract: Substituted pyrazoles, methods of manufacturing them, compositions containing them, and methods of using them to treat, for example, autoimmune diseases mediated by cathepsin S are described.
Patent AU-2002315105-B2 (AU)
Title: Apparatus and method for sculpting the surface of a bone joint
Inventor: JOHNSON WESLEY D
IPC: A61F2/958
Filed: 2002-06-14
Granted: 2007-07-12
Abstract: An apparatus for imparting force between first (232) and second (230) adjacent bones to secure an implant, the apparatus comprising: 
an impaction device (260) including an attachment portion (216) for attaching the impaction device to the second bone; and 
an implant (252) for securing to a first bone.
Patent AU-2002348749-B2 (AU)
Title: Intermediates for LHRH antagonist synthesis, process for their production, and process for LHRH antagonist production
Inventor: RASMUSSEN JON H
IPC: C07K5/08
Filed: 2002-12-23
Granted: 2008-09-04
Abstract: The invention relates to a process for preparing a tripeptide, including a salt thereof, of the formula (IX) 
Boc-D-2Nal-D-4CIPhe-D-3Pal-OH (IX) 
comprising the following consecutive steps:  (a) Reacting Boc-D-4ClPhe-OH with HONSu to form Boc-D-4ClPhe-OSu (VII);  (b) Reacting Boc-D-4ClPhe-OSu (VII) with H-D-3Pal-OH to form Boc-D-4ClPhe-D-3Pal-OH (VIII);  (c) Reacting Boc-D-4ClPhe-D-3Pal-OH (VIII) with Boc-D-2Nal-OSu prepared by reacting Boc-D-2Nal-OH with HONSu to form Boc-D-2Nal-D-4ClPhe-D-3Pal-OH (IX).
Patent AU-2002357333-B2 (AU)
Title: Alpha-(N-sulphonamido)acetamide derivatives as Beta-amyloid inhibitors
Inventor: BRONSON JOANNE J
IPC: A61K31/4164
Filed: 2002-12-20
Granted: 2008-02-28
Abstract: There is provided a series of novel alpha-(N-sulfonamido)acetamide compounds of the Formula (I) wherein R, R1, R2 and R3 are defined herein, which are inhibitors of beta-amyloid peptide (beta-AP) production and are useful in the treatment of Alzheimer's Disease and other conditions affected by anti-amyloid activity.
Patent AU-2003204276-B2 (AU)
Title: Coated medical devices for the prevention and treatment of vascular disease
Inventor: FALOTICO ROBERT
IPC: A61F2/00
Filed: 2003-05-20
Granted: 2007-09-20
Abstract: A drug and drug delivery system for use in the treatment of vascular disease is coated with rapamycin or other suitable drug, agent or compound and delivered intraluminally for the treatment and prevention of neointimal hyperplasia following percutaneous transluminal coronary angiography. The local delivery of the drugs or agents provides for increased effectiveness and lower systemic toxicity.
Patent AU-2003287291-B2 (AU)
Title: MIMO WLAN system
Inventor: WALLACE MARK S
IPC: H04J99/00
Filed: 2003-10-24
Granted: 2009-12-24
Abstract: A multiple-access MIMO WLAN system that employs MIMO, OFDM, and TDD. The system (1) uses a channel structure with a number of configurable transport channels, (2) supports multiple rates and transmission modes, which are configurable based on channel conditions and user terminal capabilities, (3) employs a pilot structure with several types of pilot (e.g., beacon, MIMO, steered reference, and carrier pilots) for different functions, (4) implements rate, timing, and power control loops for proper system operation, and (5) employs random access for system access by the user terminals, fast acknowledgement, and quick resource assignments. Calibration may be performed to account for differences in the frequency responses of transmit/receive chains at the access point and user terminals. The spatial processing may then be simplified by taking advantage of the reciprocal nature of the downlink and uplink and the calibration.
Patent AU-2004201147-B2 (AU)
Title: Immunological adjuvant compound
Inventor: ISHIZAKA SALLY T
IPC: C07F9/10
Filed: 2004-03-18
Granted: 2008-04-03
Abstract: The present invention is directed to novel compounds that function as immunological adjuvants when co-administered with antigens such as vaccines for bacterial and viral diseases, to novel adjuvant formulations which include at least one of the adjuvant compounds of the invention, to novel immunostimulatory compositions which comprise an antigen and at least one of the adjuvant compounds of the invention, and to methods for the immunization of an animal by co-administration of a compound of the invention with an antigen against which the animal is to be immunized.
Patent AU-2005270667-B2 (AU)
Title: Microarray-mediated diagnosis of Herpes Virus infection by monitoring host's differential gene expression upon infection
Inventor: REES THOMAS MERVYN
IPC: G01N33/48
Filed: 2005-08-15
Granted: 2011-08-25
Abstract: The present invention discloses microarray-based methods for the diagnosis of Herpes Virus infection from peripheral blood samples. It discloses the expression of host’s disease-associated genes and their use in assays for diagnosis and assessment of animal with herpes virus infection. This invention allows monitoring of an infected animal’s immune response and thus enables better treatment and management decisions to be made in clinical and sub-clinically affected animals.
Patent AU-2005299070-B2 (AU)
Title: Diffuse sound envelope shaping for binaural cue coding schemes and the like
Inventor: FALLER CHRISTOF
IPC: H04S3/00
Filed: 2005-09-12
Granted: 2008-12-18
Abstract: In one embodiment, C input audio channels are encoded to generate E transmitted audio channel(s), where one or more cue codes are generated for two or more of the C input channels, and the C input channels are downmixed to generate the E transmitted channel(s), where C>E≧1. One or more of the C input channels and the E transmitted channel(s) are analyzed to generate a flag indicating whether or not a decoder of the E transmitted channel(s) should perform envelope shaping during decoding of the E transmitted channel(s). In one implementation, envelope shaping adjusts a temporal envelope of a decoded channel generated by the decoder to substantially match a temporal envelope of a corresponding transmitted channel.
Patent AU-2005314563-B2 (AU)
Title: Influenza vaccination
Inventor: DEREK O'HAGAN
IPC: A61K39/145
Filed: 2005-11-03
Granted: 2011-06-30
Abstract: Influenza viruses have traditionally been administered by intramuscular injection. The invention is based on the idea of using alternative routes of delivery for influenza vaccines, more specifically routes that do not require as large a dose of antigen. Delivery of influenza antigen to the Langerhans cells is the route of choice according to the invention. This route has been found to be particularly useful for vaccinating patients who are naïve to influenza virus (i.e. have not previously mounted an immune response to an influenza virus), which means that it is advantageous for immunising young childen.
Patent AU-2005330637-B2 (AU)
Title: Oligonucleotides comprising a ligand tethered to a modified or non-natural nucleobase
Inventor: XIA JIE
IPC: C07H21/00
Filed: 2005-08-04
Granted: 2012-09-20
Abstract: One aspect of the present invention relates to a double-stranded oligonucleotide comprising at least one ligand tethered to an altered or non-natural nucleobase. In certain embodiments, the non-natural nucleobase is difluorotolyl, nitropyrrolyl, or nitroimidazolyl. In certain embodiments, the ligand is a steroid or aromatic compound. In certain embodiments, only one of the two oligonucleotide strands comprising the double-stranded oligonucleotide contains a ligand tethered to an altered or non-natural nucleobase. In certain embodiments, both of the oligonucleotide strands comprising the double-stranded oligonucleotide independently contain a ligand tethered to an altered or non-natural nucleobase. In certain embodiments, the oligonucleotide strands comprise at least one modified sugar moiety. Another aspect of the present invention relates to a single-stranded oligonucleotide comprising at least one ligand tethered to an altered or non-natural nucleobase. In certain embodiments, the non-natural nucleobase is difluorotolyl, nitropyrrolyl, or nitroimidazolyl. In certain embodiments, the ligand is a steroid or aromatic compound. In certain embodiments, the robose sugar moiety that occurs naturally in nucleosides is replaced with a hexose sugar, polycyclic heteroalkyl ring, or cyclohexenyl group. In certain embodiments, at least one phosphate linkage in the oligonucleotide has been replaced with a phosphorothioate linkage.
Patent AU-2006202744-B2 (AU)
Title: Wheel slip correction system
Inventor: AJITH KUTTANNAIR KUMAR
IPC: B61C15/12
Filed: 2006-06-26
Granted: 2012-11-29
Abstract: WHEEL SLP CORRECTION SYSTEM A wheel slip correction system for an electric traction motor propelled vehicle having a plurality of DC electric traction motors with series connected armature and field windings incorporates an apparatus connected in circuit with each motor for reducing motor armature current in response to a motor speed increase caused by wheel slip. The apparatus is arranged to be non-power dissipative during non-wheel slip conditions. 1 8N uator A 12N 14N 14A FIG. 6A 46 42 0 52j 46s Sink/ 5 Source 50) 54 ~~V FIG.. 6 C
Patent AU-2006203277-B2 (AU)
Title: Engine System with Mixed Exhaust Gas Oxygen Sensor Types
Inventor: TOBIAS PALLET
IPC: F02D41/04
Filed: 2006-08-01
Granted: 2011-11-10
Abstract: Record ID 81120288 Abstract In one example, a system for a vehicle traveling on the road is described. The system includes a first cylinder; a second cylinder; a linear exhaust gas sensor coupled exclusively to said first cylinder; a switching exhaust gas sensor coupled exclusively to said second cylinder; and a controller configured to operate in a first mode with both said first and second cylinders carrying out lean combustion, where fuel injection amounts to each of said first and second cylinder are adjusted based on said linear sensor; said controller further configured to operate in a second mode with both said first and second cylinders carrying out combustion about stoichiometry, where fuel injection amounts to at least one of said first and second cylinder are adjusted based on said switching sensor. -33- (210 230 232 ------------ 224A 1,0000"222 238 240 212 234 236 Fig. 2A - ~ ~ ~ ~ - --- 2 2 4 '000222 238 240 Fig. 2B 10 230 20 232 212 222 238 240 Fig. 2C 234 236
Patent AU-2006203771-B2 (AU)
Title: Angled reaction vessel
Inventor: NOLL ANTHONY P
IPC: B09B3/00
Filed: 2006-08-30
Granted: 2013-03-14
Abstract: The invention is an apparatus and a process for treating biomass bearing material including municipal solid waste (MSW). The apparatus includes a reaction vessel held at an angle and configured for rotation and steam injection, with helically 5 arranged internal flights, a self-aligning door closure, and a swing-away door assembly. It also includes a novel structure for shredding biomass bearing material attached to the edges of the flights. This structure is a number of projecting tooth like points and paddles.
Patent AU-2006245734-B2 (AU)
Title: Host cell specific binding molecules capable of neutralizing viruses and uses thereof
Inventor: MARK THROSBY
IPC: A61K51/10
Filed: 2006-05-11
Granted: 2011-12-01
Abstract: The present invention provides human binding molecules specifically binding to a host cell protein and having virus neutralizing activity, nucleic acid molecules encoding the human binding molecules, compositions comprising the human binding molecules and methods of identifying or producing the human binding molecules. The human binding molecules can be used in the diagnosis, prophylaxis and/or treatment of viral infections.
Patent AU-2006277905-B2 (AU)
Title: Electronic advertising panel for playing fields
Inventor: ODENA SERGIO CAMPOY
IPC: G09F9/33
Filed: 2006-08-02
Granted: 2010-08-12
Abstract: Electronic advertising billboard for playing fields, consisting of modules that include functional assemblies in a sandwich, with a metal plate (3), at least one polycarbonate sheet (4) and at least one PCB plate provided with LEDs (5.1). The assembly is held together by means of bolts (6) inserted into the metal plate (3) and through the polycarbonate sheet (4) and the PCB plate (5). This functional assembly is placed in a housing provided with hooks for joining the modules together and with legs that can be rotated between a folded position and a position for use.
Patent AU-2006296837-B2 (AU)
Title: Treatment of IBD and IBS using both probiotic bacteria and fermented cereal as treatment effectors
Inventor: ISRAELSEN HANS
IPC: A23L7/152
Filed: 2006-09-27
Granted: 2012-12-13
Abstract: The invention covers a novel treatment strategy that considerably improves conventional probiotic treatments of inflammatory bowel diseases, irritable bowel syndrome and other gastrointestinal disorders. Both probiotic microorganisms and the carrier of the probiotic microorganisms in form of a fermented cereal gruel are used as treatment effectors. Phospholipids may also be an effecter. The novel treatment strategy is capable of removing the symptoms of inflammatory bowel diseases regardless of a mild, moderate or severe stage of the disease.
Patent AU-2006320538-B2 (AU)
Title: Treatment of xerostomia with a sulfur-containing antioxidant
Inventor: SHAUER WREN HENDERSON
IPC: A61K31/426
Filed: 2006-11-29
Granted: 2013-07-04
Abstract: Xerostomia is treated with a sulfur-containing antioxidant, such as N-acetylcysteine. Delivery compositions including polyoxyalkylene block copolymers may be used, which may be formulated to exhibit reverse-thermal viscosity behavior.
Patent AU-2007266307-B2 (AU)
Title: Multi-gene expression vehicle
Inventor: HEATH ROBYN LOUISE
IPC: C12N15/09
Filed: 2007-05-24
Granted: 2012-05-31
Abstract: A multigene expression vehicle (MGEV) consisting essentially of a polynucleotide comprising 2 to 8 domain segments, D, each domain encoding a functional protein, each domain being joined to the next in a linear sequence by a Linker (L) segment encoding a Linker peptide, the D and L segments all being in the same reading frame, and at least one of the domains is not a type two protease inhibitor.
Patent AU-2007284615-B2 (AU)
Title: Method for making solid dispersions of highly crystalline therapeutic compounds
Inventor: INDRAJIT GHOSH
IPC: A61K9/16
Filed: 2007-08-14
Granted: 2011-10-27
Abstract: A process for preparing solid dispersions of highly crystalline compounds. The highly crystalline or thermally labile therapeutic compounds are processed in an extruder in combination with a solubilizing agent and optionally a plasticizer. The resulting extrudate features the therapeutic compound in an amorphous state. Particularly useful as the solubilizing agents are surfactants such as poloxamers.
Patent AU-2007311617-B2 (AU)
Title: A fluid monitoring apparatus and a method of operating the same
Inventor: BOYD NATHAN
IPC: G01N33/18
Filed: 2007-10-12
Granted: 2013-08-29
Abstract: A sampling apparatus for sampling a fluid, the apparatus comprising a sensor and a flow regulator open to allow the continuous flow of fluid through the apparatus past the sensor.
Patent AU-2007311757-B2 (AU)
Title: A cleaning device
Inventor: WALSH STEVE
IPC: A47L13/26
Filed: 2007-10-01
Granted: 2012-09-06
Abstract: The invention relates to a device for cleaning carpets, fabric and upholstery. More specifically, the invention relates to the use of pressurised aerosol containers for cleaning carpets, fabric and upholstery.
Patent AU-2007319825-B2 (AU)
Title: Oral formulations
Inventor: DALGARNO DAVID C
IPC: A61K9/14
Filed: 2007-11-14
Granted: 2014-01-23
Abstract: A solid pharmaceutical composition containing AP23573 suitable for oral administration is disclosed.
Patent AU-2007336297-B2 (AU)
Title: Magnetic nanoparticles for the application in hyperthermia, preparation thereof and use in constructs having a pharmacological application
Inventor: FERRUTI PAOLO
IPC: A61K9/127
Filed: 2007-12-18
Granted: 2013-09-05
Abstract: There are described nanoparticles of magnetic metal oxides employable in constructs consisting in polymer particles possibly also incorporating pharmacologically active substances.